1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Head and Neck Cancer Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 PD Inhibitors 1.2.3 Microtubule Inhibitors 1.2.4 EGFR Inhibitors 1.3 Market by Application 1.3.1 Global Head and Neck Cancer Therapeutics Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Surgery 1.3.3 Radiation therapy 1.3.4 Chemotherapy 1.3.5 Immunotherapy 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Head and Neck Cancer Therapeutics Market Perspective (2017-2028) 2.2 Head and Neck Cancer Therapeutics Growth Trends by Region 2.2.1 Head and Neck Cancer Therapeutics Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Head and Neck Cancer Therapeutics Historic Market Size by Region (2017-2022) 2.2.3 Head and Neck Cancer Therapeutics Forecasted Market Size by Region (2023-2028) 2.3 Head and Neck Cancer Therapeutics Market Dynamics 2.3.1 Head and Neck Cancer Therapeutics Industry Trends 2.3.2 Head and Neck Cancer Therapeutics Market Drivers 2.3.3 Head and Neck Cancer Therapeutics Market Challenges 2.3.4 Head and Neck Cancer Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Head and Neck Cancer Therapeutics Players by Revenue 3.1.1 Global Top Head and Neck Cancer Therapeutics Players by Revenue (2017-2022) 3.1.2 Global Head and Neck Cancer Therapeutics Revenue Market Share by Players (2017-2022) 3.2 Global Head and Neck Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Head and Neck Cancer Therapeutics Revenue 3.4 Global Head and Neck Cancer Therapeutics Market Concentration Ratio 3.4.1 Global Head and Neck Cancer Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Head and Neck Cancer Therapeutics Revenue in 2021 3.5 Head and Neck Cancer Therapeutics Key Players Head office and Area Served 3.6 Key Players Head and Neck Cancer Therapeutics Product Solution and Service 3.7 Date of Enter into Head and Neck Cancer Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Head and Neck Cancer Therapeutics Breakdown Data by Type 4.1 Global Head and Neck Cancer Therapeutics Historic Market Size by Type (2017-2022) 4.2 Global Head and Neck Cancer Therapeutics Forecasted Market Size by Type (2023-2028) 5 Head and Neck Cancer Therapeutics Breakdown Data by Application 5.1 Global Head and Neck Cancer Therapeutics Historic Market Size by Application (2017-2022) 5.2 Global Head and Neck Cancer Therapeutics Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Head and Neck Cancer Therapeutics Market Size (2017-2028) 6.2 North America Head and Neck Cancer Therapeutics Market Size by Country (2017-2022) 6.3 North America Head and Neck Cancer Therapeutics Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Head and Neck Cancer Therapeutics Market Size (2017-2028) 7.2 Europe Head and Neck Cancer Therapeutics Market Size by Country (2017-2022) 7.3 Europe Head and Neck Cancer Therapeutics Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Head and Neck Cancer Therapeutics Market Size (2017-2028) 8.2 Asia-Pacific Head and Neck Cancer Therapeutics Market Size by Country (2017-2022) 8.3 Asia-Pacific Head and Neck Cancer Therapeutics Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Head and Neck Cancer Therapeutics Market Size (2017-2028) 9.2 Latin America Head and Neck Cancer Therapeutics Market Size by Country (2017-2022) 9.3 Latin America Head and Neck Cancer Therapeutics Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Head and Neck Cancer Therapeutics Market Size (2017-2028) 10.2 Middle East & Africa Head and Neck Cancer Therapeutics Market Size by Country (2017-2022) 10.3 Middle East & Africa Head and Neck Cancer Therapeutics Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Sanofi 11.1.1 Sanofi Company Detail 11.1.2 Sanofi Business Overview 11.1.3 Sanofi Head and Neck Cancer Therapeutics Introduction 11.1.4 Sanofi Revenue in Head and Neck Cancer Therapeutics Business (2017-2022) 11.1.5 Sanofi Recent Development 11.2 Eli Lilly 11.2.1 Eli Lilly Company Detail 11.2.2 Eli Lilly Business Overview 11.2.3 Eli Lilly Head and Neck Cancer Therapeutics Introduction 11.2.4 Eli Lilly Revenue in Head and Neck Cancer Therapeutics Business (2017-2022) 11.2.5 Eli Lilly Recent Development 11.3 Amgen 11.3.1 Amgen Company Detail 11.3.2 Amgen Business Overview 11.3.3 Amgen Head and Neck Cancer Therapeutics Introduction 11.3.4 Amgen Revenue in Head and Neck Cancer Therapeutics Business (2017-2022) 11.3.5 Amgen Recent Development 11.4 Actavis 11.4.1 Actavis Company Detail 11.4.2 Actavis Business Overview 11.4.3 Actavis Head and Neck Cancer Therapeutics Introduction 11.4.4 Actavis Revenue in Head and Neck Cancer Therapeutics Business (2017-2022) 11.4.5 Actavis Recent Development 11.5 Dr. Reddy’s Laboratories 11.5.1 Dr. Reddy’s Laboratories Company Detail 11.5.2 Dr. Reddy’s Laboratories Business Overview 11.5.3 Dr. Reddy’s Laboratories Head and Neck Cancer Therapeutics Introduction 11.5.4 Dr. Reddy’s Laboratories Revenue in Head and Neck Cancer Therapeutics Business (2017-2022) 11.5.5 Dr. Reddy’s Laboratories Recent Development 11.6 Jiangsu Hengrui 11.6.1 Jiangsu Hengrui Company Detail 11.6.2 Jiangsu Hengrui Business Overview 11.6.3 Jiangsu Hengrui Head and Neck Cancer Therapeutics Introduction 11.6.4 Jiangsu Hengrui Revenue in Head and Neck Cancer Therapeutics Business (2017-2022) 11.6.5 Jiangsu Hengrui Recent Development 11.7 Teva Pharmaceutical 11.7.1 Teva Pharmaceutical Company Detail 11.7.2 Teva Pharmaceutical Business Overview 11.7.3 Teva Pharmaceutical Head and Neck Cancer Therapeutics Introduction 11.7.4 Teva Pharmaceutical Revenue in Head and Neck Cancer Therapeutics Business (2017-2022) 11.7.5 Teva Pharmaceutical Recent Development 11.8 DFG 11.8.1 DFG Company Detail 11.8.2 DFG Business Overview 11.8.3 DFG Head and Neck Cancer Therapeutics Introduction 11.8.4 DFG Revenue in Head and Neck Cancer Therapeutics Business (2017-2022) 11.8.5 DFG Recent Development 11.9 BioXpress 11.9.1 BioXpress Company Detail 11.9.2 BioXpress Business Overview 11.9.3 BioXpress Head and Neck Cancer Therapeutics Introduction 11.9.4 BioXpress Revenue in Head and Neck Cancer Therapeutics Business (2017-2022) 11.9.5 BioXpress Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Head and Neck Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of PD Inhibitors Table 3. Key Players of Microtubule Inhibitors Table 4. Key Players of EGFR Inhibitors Table 5. Global Head and Neck Cancer Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Head and Neck Cancer Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Head and Neck Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Head and Neck Cancer Therapeutics Market Share by Region (2017-2022) Table 9. Global Head and Neck Cancer Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Head and Neck Cancer Therapeutics Market Share by Region (2023-2028) Table 11. Head and Neck Cancer Therapeutics Market Trends Table 12. Head and Neck Cancer Therapeutics Market Drivers Table 13. Head and Neck Cancer Therapeutics Market Challenges Table 14. Head and Neck Cancer Therapeutics Market Restraints Table 15. Global Head and Neck Cancer Therapeutics Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Head and Neck Cancer Therapeutics Market Share by Players (2017-2022) Table 17. Global Top Head and Neck Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Head and Neck Cancer Therapeutics as of 2021) Table 18. Ranking of Global Top Head and Neck Cancer Therapeutics Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Head and Neck Cancer Therapeutics Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Head and Neck Cancer Therapeutics Product Solution and Service Table 22. Date of Enter into Head and Neck Cancer Therapeutics Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Head and Neck Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Head and Neck Cancer Therapeutics Revenue Market Share by Type (2017-2022) Table 26. Global Head and Neck Cancer Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Head and Neck Cancer Therapeutics Revenue Market Share by Type (2023-2028) Table 28. Global Head and Neck Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Head and Neck Cancer Therapeutics Revenue Market Share by Application (2017-2022) Table 30. Global Head and Neck Cancer Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Head and Neck Cancer Therapeutics Revenue Market Share by Application (2023-2028) Table 32. North America Head and Neck Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Head and Neck Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Head and Neck Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Head and Neck Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Head and Neck Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Head and Neck Cancer Therapeutics Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Head and Neck Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Head and Neck Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Head and Neck Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Head and Neck Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 42. Sanofi Company Detail Table 43. Sanofi Business Overview Table 44. Sanofi Head and Neck Cancer Therapeutics Product Table 45. Sanofi Revenue in Head and Neck Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 46. Sanofi Recent Development Table 47. Eli Lilly Company Detail Table 48. Eli Lilly Business Overview Table 49. Eli Lilly Head and Neck Cancer Therapeutics Product Table 50. Eli Lilly Revenue in Head and Neck Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 51. Eli Lilly Recent Development Table 52. Amgen Company Detail Table 53. Amgen Business Overview Table 54. Amgen Head and Neck Cancer Therapeutics Product Table 55. Amgen Revenue in Head and Neck Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 56. Amgen Recent Development Table 57. Actavis Company Detail Table 58. Actavis Business Overview Table 59. Actavis Head and Neck Cancer Therapeutics Product Table 60. Actavis Revenue in Head and Neck Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 61. Actavis Recent Development Table 62. Dr. Reddy’s Laboratories Company Detail Table 63. Dr. Reddy’s Laboratories Business Overview Table 64. Dr. Reddy’s Laboratories Head and Neck Cancer Therapeutics Product Table 65. Dr. Reddy’s Laboratories Revenue in Head and Neck Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 66. Dr. Reddy’s Laboratories Recent Development Table 67. Jiangsu Hengrui Company Detail Table 68. Jiangsu Hengrui Business Overview Table 69. Jiangsu Hengrui Head and Neck Cancer Therapeutics Product Table 70. Jiangsu Hengrui Revenue in Head and Neck Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 71. Jiangsu Hengrui Recent Development Table 72. Teva Pharmaceutical Company Detail Table 73. Teva Pharmaceutical Business Overview Table 74. Teva Pharmaceutical Head and Neck Cancer Therapeutics Product Table 75. Teva Pharmaceutical Revenue in Head and Neck Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 76. Teva Pharmaceutical Recent Development Table 77. DFG Company Detail Table 78. DFG Business Overview Table 79. DFG Head and Neck Cancer Therapeutics Product Table 80. DFG Revenue in Head and Neck Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 81. DFG Recent Development Table 82. BioXpress Company Detail Table 83. BioXpress Business Overview Table 84. BioXpress Head and Neck Cancer Therapeutics Product Table 85. BioXpress Revenue in Head and Neck Cancer Therapeutics Business (2017-2022) & (US$ Million) Table 86. BioXpress Recent Development Table 87. Research Programs/Design for This Report Table 88. Key Data Information from Secondary Sources Table 89. Key Data Information from Primary Sources List of Figures Figure 1. Global Head and Neck Cancer Therapeutics Market Share by Type: 2021 VS 2028 Figure 2. PD Inhibitors Features Figure 3. Microtubule Inhibitors Features Figure 4. EGFR Inhibitors Features Figure 5. Global Head and Neck Cancer Therapeutics Market Share by Application in 2021 & 2028 Figure 6. Surgery Case Studies Figure 7. Radiation therapy Case Studies Figure 8. Chemotherapy Case Studies Figure 9. Immunotherapy Case Studies Figure 10. Head and Neck Cancer Therapeutics Report Years Considered Figure 11. Global Head and Neck Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Head and Neck Cancer Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Head and Neck Cancer Therapeutics Market Share by Region: 2021 VS 2028 Figure 14. Global Head and Neck Cancer Therapeutics Market Share by Players in 2021 Figure 15. Global Top Head and Neck Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Head and Neck Cancer Therapeutics as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Head and Neck Cancer Therapeutics Revenue in 2021 Figure 17. North America Head and Neck Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. North America Head and Neck Cancer Therapeutics Market Share by Country (2017-2028) Figure 19. United States Head and Neck Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Canada Head and Neck Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Head and Neck Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Head and Neck Cancer Therapeutics Market Share by Country (2017-2028) Figure 23. Germany Head and Neck Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. France Head and Neck Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. U.K. Head and Neck Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Italy Head and Neck Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Russia Head and Neck Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Nordic Countries Head and Neck Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Head and Neck Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Head and Neck Cancer Therapeutics Market Share by Region (2017-2028) Figure 31. China Head and Neck Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Japan Head and Neck Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. South Korea Head and Neck Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Southeast Asia Head and Neck Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. India Head and Neck Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Australia Head and Neck Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Head and Neck Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Head and Neck Cancer Therapeutics Market Share by Country (2017-2028) Figure 39. Mexico Head and Neck Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Brazil Head and Neck Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Head and Neck Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Head and Neck Cancer Therapeutics Market Share by Country (2017-2028) Figure 43. Turkey Head and Neck Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Saudi Arabia Head and Neck Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Sanofi Revenue Growth Rate in Head and Neck Cancer Therapeutics Business (2017-2022) Figure 46. Eli Lilly Revenue Growth Rate in Head and Neck Cancer Therapeutics Business (2017-2022) Figure 47. Amgen Revenue Growth Rate in Head and Neck Cancer Therapeutics Business (2017-2022) Figure 48. Actavis Revenue Growth Rate in Head and Neck Cancer Therapeutics Business (2017-2022) Figure 49. Dr. Reddy’s Laboratories Revenue Growth Rate in Head and Neck Cancer Therapeutics Business (2017-2022) Figure 50. Jiangsu Hengrui Revenue Growth Rate in Head and Neck Cancer Therapeutics Business (2017-2022) Figure 51. Teva Pharmaceutical Revenue Growth Rate in Head and Neck Cancer Therapeutics Business (2017-2022) Figure 52. DFG Revenue Growth Rate in Head and Neck Cancer Therapeutics Business (2017-2022) Figure 53. BioXpress Revenue Growth Rate in Head and Neck Cancer Therapeutics Business (2017-2022) Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed

Sanofi Eli Lilly Amgen Actavis Dr. Reddy’s Laboratories Jiangsu Hengrui Teva Pharmaceutical DFG BioXpress